Lipoprotein(a) in atherosclerotic plaques recruits inflammatory cells through interaction with Mac-1 integrin

被引:102
作者
Sotiriou, SN
Orlova, VV
Al-Fakhri, N
Ihanus, E
Economopoulou, M
Isermann, B
Bdeir, K
Nawroth, PP
Preissner, KT
Gahmberg, CG
Koschinsky, ML
Chavakis, T
机构
[1] Natl Canc Inst, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA
[2] Heidelberg Univ, Dept Internal Med 1, Heidelberg, Germany
[3] Univ Marburg, Dept Clin Chem & Mol Diagnost, Marburg, Germany
[4] Univ Helsinki, Fac Biosci, Div Biochem, FIN-00014 Helsinki, Finland
[5] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[6] Univ Giessen, Inst Biochem, Giessen, Germany
[7] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada
关键词
plasminogen/angiostatin kringle 4; coronary arteries; prothrombotic tissue factor;
D O I
10.1096/fj.05-4857fje
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lipoprotein(a) [Lp(a)], consisting of LDL and the unique constituent apolipoprotein(a) [apo(a)], which contains multiple repeats resembling plasminogen kringle 4, is considered a risk factor for the development of atherosclerotic disorders. However, the underlying mechanisms for the atherogenicity of Lp(a) are not completely understood. Here, we define a novel function of Lp(a) in promoting inflammatory cell recruitment that may contribute to its atherogenicity. Through its apo(a) moiety Lp(a) specifically interacts with the beta 2-integrin Mac-1, thereby promoting the adhesion of monocytes and their transendothelial migration in a Mac-1-dependent manner. Interestingly, the interaction between Mac-1 and Lp(a) was strengthened in the presence of proatherogenic homocysteine and was blocked by plasminogen/angiostatin kringle 4. Through its interaction with Mac-1, Lp(a) induced activation of the proinflammatory transcription factor NF kappa B, as well as the NF kappa B-related expression of prothrombotic tissue factor. In atherosclerotic coronary arteries Lp(a) was found to be localized in close proximity to Mac-1 on infiltrating mononuclear cells. Taken together, our data demonstrate that Lp(a), via its apo(a) moiety, is a ligand for the beta 2-integrin Mac-1, thereby facilitating inflammatory cell recruitment to atherosclerotic plaques. These observations suggest a novel mechanism for the atherogenic properties of Lp(a).
引用
收藏
页码:559 / +
页数:23
相关论文
共 58 条
[1]   Expression of adhesion molecules by Lp(a): a potential novel mechanism for its atherogenicity [J].
Allen, S ;
Khan, S ;
Tam, SP ;
Koschinsky, M ;
Taylor, P ;
Yacoub, M .
FASEB JOURNAL, 1998, 12 (15) :1765-1776
[2]  
Anglés-Cano E, 2001, ANN NY ACAD SCI, V936, P261
[3]   Mechanisms of disease - Nuclear factor-kappa b - A pivotal transcription factor in chronic inflammatory diseases [J].
Barnes, PJ ;
Larin, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (15) :1066-1071
[4]   Identification of sequences in apolipoprotein(a) that maintain its closed conformation: A novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation [J].
Becker, L ;
Cook, PM ;
Koschinsky, ML .
BIOCHEMISTRY, 2004, 43 (31) :9978-9988
[5]   Diabetes-associated sustained activation of the transcription factor nuclear factor-κB [J].
Bierhaus, A ;
Schiekofer, S ;
Schwaninger, M ;
Andrassy, M ;
Humpert, PM ;
Chen, J ;
Hong, M ;
Luther, T ;
Henle, T ;
Klöting, I ;
Morcos, M ;
Hofmann, M ;
Tritschler, H ;
Weigle, B ;
Kasper, M ;
Smith, M ;
Perry, G ;
Schmidt, AM ;
Stern, DM ;
Häring, HU ;
Schleicher, E ;
Nawroth, PP .
DIABETES, 2001, 50 (12) :2792-2808
[6]   MECHANISM OF THE TUMOR-NECROSIS-FACTOR ALPHA-MEDIATED INDUCTION OF ENDOTHELIAL TISSUE FACTOR [J].
BIERHAUS, A ;
ZHANG, YM ;
DENG, YH ;
MACKMAN, N ;
QUEHENBERGER, P ;
HAASE, M ;
LUTHER, T ;
MULLER, M ;
BOHRER, H ;
GRETEN, J ;
MARTIN, E ;
BAEUERLE, PA ;
WALDHERR, R ;
KISIEL, W ;
ZIEGLER, R ;
STERN, DM ;
NAWROTH, PP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) :26419-26432
[7]   A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice [J].
Boisvert, WA ;
Santiago, R ;
Curtiss, LK ;
Terkeltaub, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (02) :353-363
[8]   ATHEROGENESIS IN TRANSGENIC MICE WITH HUMAN APOLIPOPROTEIN-B AND LIPOPROTEIN (A) [J].
CALLOW, MJ ;
VERSTUYFT, J ;
TANGIRALA, R ;
PALINSKI, W ;
RUBIN, EM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (03) :1639-1646
[9]   Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis [J].
Caplice, NM ;
Panetta, C ;
Peterson, TE ;
Kleppe, LS ;
Mueske, CS ;
Kostner, GM ;
Broze, GJ ;
Simari, RD .
BLOOD, 2001, 98 (10) :2980-2987
[10]  
Chavakis E, 2001, CIRCULATION, V103, P2102